{
    "organizations": [],
    "uuid": "a6626c2e20497517422e9b6b374de47c94b08043",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-vivus-says-john-amos-appointed-ceo/brief-vivus-says-john-amos-appointed-ceo-idUSASC09YCA",
    "ord_in_thread": 0,
    "title": "BRIEF-Vivus Says John Amos Appointed CEO",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 30 (Reuters) - Vivus Inc:\n* SAYS JOHN AMOS APPOINTED CEO * SCOTT OEHRLEIN IS CHIEF OPERATIONS OFFICER, A NEWLY CREATED POSITION WITHIN COMPANY\n* KENNETH SUH WILL CONTINUE AS PRESIDENT AND CEO OF WILLOW BIOPHARMA INC., NOW A WHOLLY-OWNED SUBSIDIARY OF VIVUS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-01T04:25:00.000+03:00",
    "crawled": "2018-05-01T20:19:10.033+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "vivus",
        "inc",
        "say",
        "john",
        "amos",
        "appointed",
        "ceo",
        "scott",
        "oehrlein",
        "chief",
        "operation",
        "officer",
        "newly",
        "created",
        "position",
        "within",
        "company",
        "kenneth",
        "suh",
        "continue",
        "president",
        "ceo",
        "willow",
        "biopharma",
        "subsidiary",
        "vivus",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}